David Ayers to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications David Ayers has written about Xenograft Model Antitumor Assays.
Connection Strength
0.021
-
Jones MD, Liu JC, Barthel TK, Hussain S, Lovria E, Cheng D, Schoonmaker JA, Mulay S, Ayers DC, Bouxsein ML, Stein GS, Mukherjee S, Lian JB. A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes. Clin Cancer Res. 2010 Oct 15; 16(20):4978-89.
Score: 0.021